Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Cutis
|
July 1, 1980
Trichotillomania in adults
M Sticher, W Abramovits, V D Newcomer
Antimicrobial Agents and Chemotherapy
|
November 27, 2019
Analysis of the Potential for <i>N</i><sup>4</sup>-Hydroxycytidine To Inhibit Mitochondrial Replication and Function
Zachary M Sticher, Gaofei Lu, Deborah G Mitchell, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
Katherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Journal of Virology
|
August 29, 2024
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection
Carolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection
Carolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Nature Communications
|
September 3, 2021
Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding
Kevin Wittwer, Danielle E Anderson, Kristin Pfeffermann, et al.
Antiviral Research
|
September 9, 2019
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
George R Painter, Richard A Bowen, Gregory R Bluemling, et al.
Biorxiv : the Preprint Server for Biology
|
December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets
Robert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Nature Communications
|
July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
Carolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications
|
August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
Robert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Cutis
|
July 1, 1980
Trichotillomania in adults
M Sticher, W Abramovits, V D Newcomer
Antimicrobial Agents and Chemotherapy
|
November 27, 2019
Analysis of the Potential for <i>N</i><sup>4</sup>-Hydroxycytidine To Inhibit Mitochondrial Replication and Function
Zachary M Sticher, Gaofei Lu, Deborah G Mitchell, et al.
Antimicrobial Agents and Chemotherapy
|
June 17, 2020
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
Katherine E Squires, Douglas L Mayers, Gregory R Bluemling, et al.
Journal of Virology
|
August 29, 2024
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection
Carolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection
Carolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.
Nature Communications
|
September 3, 2021
Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding
Kevin Wittwer, Danielle E Anderson, Kristin Pfeffermann, et al.
Antiviral Research
|
September 9, 2019
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
George R Painter, Richard A Bowen, Gregory R Bluemling, et al.
Biorxiv : the Preprint Server for Biology
|
December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets
Robert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Nature Communications
|
July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
Carolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications
|
August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
Robert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Page
of 2